Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Why Did Ramaco Resources (NASDAQ:METC) Adjusted EBITDA Fall 64% on 24% Higher Revenue?

The company cut 2026 production guidance to 3.5 million to 3.6 million tons from 3.6 million to 3.9 million, and sales guidance to 4.0 million to 4.1 million tons from 4.0 million to 4.3 million. Cash cost guidance rose to USD 101 to USD …

Vinay Lochav | 04 November 2026

Why Is The Children's Place (NASDAQ:PLCE) Near USD 1.05 While JetBlue Airways (NASDAQ:JBLU), Eastman Kodak (NYSE:KODK) and Optimum Communications (NYSE:OPTU) Face Their Own Pressure?

Key HighlightsThe Children's Place (NASDAQ:PLCE) closed at USD 1.05 on October 23, 2026, near a 52-week low of USD 1.00, according to published market data, with trailing twelve monthRevenuedown 15.9% to about USD 1.13 billion.JetBlue Airways (NASDAQ:JBLU) lost USD 257 million in the third …

Vinay Lochav | 04 November 2026

Can Melco Resorts & Entertainment (NASDAQ:MLCO) Hold a 7.38% Gain Into Earnings?

The most recent filed quarter, ended June 30, 2026, showed operating revenues of USD 1.25 billion, down about 6% from USD 1.33 billion, driven by softer rolling chip and mass-market table play. City of Dreams adjusted EBITDA fell to USD 147.8 million from USD …

Vinay Lochav | 04 November 2026

How Did Revenue Jump 53% at Frontier Group Holdings (NASDAQ:ULCC) While Carter's (NYSE:CRI), Camping World (NYSE:CWH) and First Watch Restaurant Group (NASDAQ:FWRG) Posted Mixed Profits?

Key HighlightsFrontier Group Holdings (NASDAQ:ULCC) reported third-quarter 2026Revenueof USD 1.355 billion, up 53%, with adjustedNet Incomeof USD 40 million but aGAAPnet loss of USD 104 million.Carter's (NYSE:CRI) reported third quarter fiscal 2026 GAAP diluted EPS of USD 1.00 against USD 0.32 on net sales …

Vinay Lochav | 04 November 2026

What Is Priced Into Mineralys Therapeutics (NASDAQ:MLYS) at USD 16.11 Before a December 22 FDA Date?

The company's reported losses are large because of the Tanabe payment. Second-quarterResearch and Developmentexpense rose to USD 221.4 million from USD 38.3 million, mainly because of the USD 200.0 million upfront payment, while general and administrative expense was USD 24.7 million. The net loss …

Vinay Lochav | 04 November 2026

How Did Precigen (NASDAQ:PGEN) Lift Revenue to USD 55.0 Million as Capricor Therapeutics (NASDAQ:CAPR), Melco Resorts & Entertainment (NASDAQ:MLCO) and FTAI Infrastructure (NASDAQ:FIP) Await Catalysts?

Key HighlightsPrecigen (NASDAQ:PGEN) reported second quarter 2026Revenueof USD 55.0 million versus USD 0.9 million a year earlier, withNet Incomeof USD 20.1 million against a loss of USD 26.6 million.Capricor Therapeutics (NASDAQ:CAPR) saw the FDA extend its deramiocel action date from August 22 to November …

Vinay Lochav | 04 November 2026

Why Is Medical Properties Trust (NYSE:MPT) Penny Stock Up 4.95% After a USD 202 Million Quarter?

The one-time gains explain why net income swung positive while normalized FFO, the measure many real estate investors prefer, declined. The company completed about USD 2.4 billion of secured notes that repaid the 2026 notes and about half of the 2027 notes. Cash and …

Vinay Lochav | 04 November 2026

How Did Nordic American Tankers (NYSE:NAT) Lift Its Quarterly Net Result to USD 68.3 Million?

The USD 0.27 dividend compares with USD 0.22 for the first quarter. The company sold one 2003-built vessel for USD 26 million and has two newbuildings on order for 2028 delivery. Financing comes from a USD 150 millionFacilitywith Beal Bank secured on seven ships, …

Vinay Lochav | 04 November 2026

Why Is NIO (NYSE:NIO) Near USD 3.36 When Q3 Deliveries Jumped 25.4%?

Key HighlightsNIO (NYSE:NIO) delivered 109,178 vehicles in the third quarter of 2026, up 25.4% year over year, and 300,301 in the first nine months, up 49.2%, according to the company release.September deliveries were 37,408, up 7.7%, split into 21,318 NIO brand, 8,763 ONVO and …

Vinay Lochav | 04 November 2026

Why Is Ocugen (NASDAQ:OCGN) a Penny Stock With USD 100.4 Million in Cash?

The second quarterBusinessupdate lists OCU400 for retinitis pigmentosa with topline data in the first quarter of 2027 and a BLA in the second quarter of 2027, OCU410ST for Stargardt disease with an interim analysis in the third quarter of 2026 and a BLA around …

Vinay Lochav | 04 November 2026
Support

Hi! How can we help you today?

Loading…